Placenta Stem Cells for Foot Ulcer

This trial aims to determine if placental stem cells can safely treat diabetic foot ulcers that resist healing. Participants must have Type 2 diabetes for at least a year and a foot ulcer that hasn't improved for over four weeks, despite standard treatments like special casts or wraps. Candidates should not have changed their diabetes medication in the last two weeks. As a Phase 1 trial, the research focuses on understanding how the treatment works in people, offering participants the opportunity to be among the first to receive this innovative treatment.

Research has shown that placenta stem cells are generally safe for treating diabetic foot ulcers. One study found no serious side effects from these cells and reported complete healing in 38.5% of cases, compared to 22.6% with a placebo. Another study noted faster wound healing with placenta stem cell treatments. While the results are promising, the long-term safety and benefits remain under investigation. Overall, evidence suggests that placenta stem cells could be a safe option for improving wound healing in diabetic foot ulcers.¹²³⁴⁵

Unlike the standard treatments for diabetic foot ulcers, which typically involve wound care, antibiotics, and sometimes surgery, placenta stem cells offer a novel approach by promoting healing at the cellular level. These stem cells have the potential to regenerate damaged tissue and improve blood flow, addressing the root cause of non-healing ulcers. Researchers are excited about this treatment because it could significantly speed up the healing process and reduce complications for patients with diabetic foot ulcers, offering a promising alternative to existing care methods.

Research has shown that stem cells from the placenta may help heal stubborn diabetic foot sores. In one study, 51 out of 59 patients experienced complete healing of their sores within six months. Another study found that treatments using placenta cells accelerated wound healing and improved overall outcomes. In this trial, participants with type 2 diabetes and non-healing foot ulcers will receive placenta stem cell treatment to evaluate its effectiveness. These stem cells have proven particularly effective, with some sores healing entirely in just three weeks. Overall, these treatments appear to speed up healing and reduce the risk of major amputations.¹⁴⁵⁶⁷